Skip to main content
. Author manuscript; available in PMC: 2013 Jan 15.
Published in final edited form as: J Am Stat Assoc. 2012 Jul 24;107(498):542–554. doi: 10.1080/01621459.2011.646932

Figure 1.

Figure 1

Number of patients at each stage. “Switch early” is defined as switching to second-line regimen less than 8 weeks after confirmed virologic failure.